| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.003 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |